From a healthy babies program to crime prevention, Nurse-Family Partnership is validated by research.
A cornerstone of Nurse-Family Partnership is the extensive research on the model conducted over the last three decades. Randomized controlled trials were conducted with three diverse populations beginning in Elmira, New York, in 1977; in Memphis, Tennessee, in 1990; and in Denver, Colorado, in 1994. All three trials targeted first-time, low-income mothers. Follow-up research continues today, studying the long-term outcomes for mothers and children in these three trials.
The level of proven effectiveness demonstrated is unsurpassed in evidence-based home visitation programs. The outcomes listed below have been observed among participants in at least one of the trials of the program.
About the research
A randomized controlled trial is the most rigorous research method for measuring the effectiveness of an intervention. This type of trial is required by the U.S. Food and Drug Administration (FDA) for new drugs or medical devices to determine their effectiveness and safety before they are made available to the public. Because of their cost and complexity, these kinds of trials are not often used to evaluate complex health and human services.
In addition, important data from all home visits are continuously collected from Nurse-Family Partnership local agencies through the Nurse-Family Partnership National Service Office’s web-based data collection system. These data are analyzed and returned to local Nurse-Family Partnership agencies to provide them with information on their progress toward meeting Nurse-Family Partnership’s implementation benchmarks in improving maternal and child health.